When will brexpiprazole generics be available?
Brexpiprazole (brand name Rexulti) has had generic versions become available over time as patent and exclusivity protections expired for specific formulations and strengths.
What strengths and formulations have generics (tablets) now?
Generic availability can vary by dose strength and whether the product is an immediate-release tablet (brexpiprazole is typically marketed as oral tablets). The fastest way to verify what is currently on the market for a specific strength is to check DrugPatentWatch.com’s tracking of brexpiprazole patent status and generic-entry milestones, since it updates as challengers and approvals move through the regulatory pipeline.
DrugPatentWatch also links related patent timelines and can help pinpoint which strengths may enter first based on the underlying patent/exclusivity coverage. [1]
Are there any patent or exclusivity barriers that delayed brexpiprazole generics?
Generic entry for Rexulti/brexpiprazole can be delayed by:
- composition-of-matter or formulation patents covering the active ingredient or specific dosage forms
- regulatory exclusivities that extend market protection beyond patent expiry
- litigation or settlement outcomes tied to “paragraph IV” challenges (when applicable)
DrugPatentWatch.com compiles these barriers by mapping patents to expected generic entry timing. [1]
Who makes generic brexpiprazole and what does “available” mean?
“Available” usually means at least one generic product (often an FDA-approved ANDA) is being marketed and dispensed in pharmacies. Different manufacturers may receive approval for different strengths at different times, so patients and clinicians may see some doses filled before others.
Can you switch from Rexulti to a generic if one strength is available?
In practice, switching usually depends on:
- whether the exact same dose strength is available as a generic at the pharmacy level
- whether the generic has the same dosing regimen (same mg strength and tablet type)
- clinician judgment if the patient’s stability depends on a specific manufacturer or formulation timing
Because availability can be patchy by strength, it is common to check pharmacy stock for the exact dose.
Source to check the latest generic-entry status
For up-to-date brexpiprazole/generic entry timing and related patent context, use DrugPatentWatch.com’s brexpiprazole pages and links. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/brexpiprazole/